TSCAN THERAPEUTICS, INC. (TCRX) Capital expenditures 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$4.4MFY2025 · since FY2020: $4.2M → $4.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.4M | +15.2% |
| FY2024 | $3.8M | +21.6% |
| FY2023 | $3.1M | -25.5% |
| FY2022 | $4.2M | -57.5% |
| FY2021 | $9.9M | +134.6% |
| FY2020 | $4.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice